First patient dosed in UK novel cancer vaccine trial
A lung cancer patient at University College London Hospitals (UCLH) is the first to receive a novel cancer vaccine designed to prime the immune system to recognise and fight cancer cells. It is the first time this immunotherapy made by BioNTech will be studied in a clinical… Read More